Literature DB >> 9751276

Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids.

J C Le Bail1, F Varnat, J C Nicolas, G Habrioux.   

Abstract

The interaction between the estrogen receptor and a variety of flavonoids was studied in the presence or absence of estradiol using a stably-transfected human breast cancer cell line (MVLN). On the other hand, flavonoids were evaluated for their effects on proliferation in estrogen-dependent (MCF-7) and independent (MDA-MB231) human breast cancer cells. We established a relationship structure-activity and determined regions and/or substituents essential for estrogenic or antiestrogenic activities. In contrast, we did not find the same relationship for cell proliferation. Among all flavonoids used, only 7-methoxyflavanone and 7,8-dihydroxyflavone at high concentrations (50 microM) possess antiestrogenic and antiproliferative activities. These results suggest that two hydroxyls (in positions 7 and 8) or 7-methoxy substituents are essential for the antiestrogenic activity of flavonoids. However, it seems that flavonoids at high concentrations exert their antiproliferative activity through other estrogen receptor-independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9751276     DOI: 10.1016/s0304-3835(98)00141-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  32 in total

1.  Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin.

Authors:  Steven K Nordeen; Betty J Bona; David N Jones; James R Lambert; Twila A Jackson
Journal:  Horm Cancer       Date:  2013-07-09       Impact factor: 3.869

2.  Synthesis and aromatase inhibitory activity of flavanones.

Authors:  Christelle Pouget; Catherine Fagnere; Jean-Philippe Basly; Anne-Elise Besson; Yves Champavier; Gerard Habrioux; Albert-Jose Chulia
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

3.  The soya isoflavone content of rat diet can increase anxiety and stress hormone release in the male rat.

Authors:  David E Hartley; Jessica E Edwards; Claire E Spiller; Nazmul Alom; Sonia Tucci; Pallab Seth; Mary L Forsling; Sandra E File
Journal:  Psychopharmacology (Berl)       Date:  2003-03-05       Impact factor: 4.530

4.  Comparative Developmental Toxicity of Flavonoids Using an Integrative Zebrafish System.

Authors:  Sean M Bugel; Josephine A Bonventre; Robert L Tanguay
Journal:  Toxicol Sci       Date:  2016-08-04       Impact factor: 4.849

5.  Stimulatory and inhibitory effects of genistein on human uterine leiomyoma cell proliferation are influenced by the concentration.

Authors:  A B Moore; L Castro; L Yu; X Zheng; X Di; M I Sifre; G E Kissling; R R Newbold; C D Bortner; D Dixon
Journal:  Hum Reprod       Date:  2007-08-27       Impact factor: 6.918

6.  Cell bioassays for detection of aryl hydrocarbon (AhR) and estrogen receptor (ER) mediated activity in environmental samples.

Authors:  K Hilscherova; M Machala; K Kannan; A L Blankenship; J P Giesy
Journal:  Environ Sci Pollut Res Int       Date:  2000       Impact factor: 4.223

7.  Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors.

Authors:  Erica Amato; Tony Bankemper; Rebecca Kidney; Thuy Do; Alma Onate; Fathima Shazna Thowfeik; Edward J Merino; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2013-12-05       Impact factor: 3.641

8.  Naringenin: a partial agonist on estrogen receptor in T47D-KBluc breast cancer cells.

Authors:  Sunzoo Kim; Tae In Park
Journal:  Int J Clin Exp Med       Date:  2013-10-25

Review 9.  Tamoxifen resistance and epigenetic modifications in breast cancer cell lines.

Authors:  Eric Badia; Joan Oliva; Patrick Balaguer; Vincent Cavaillès
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

10.  Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up.

Authors:  Davaasambuu Ganmaa; Walter C Willett; Tricia Y Li; Diane Feskanich; Rob M van Dam; Esther Lopez-Garcia; David J Hunter; Michelle D Holmes
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.